Halobetasol Propionate
CAS No. 66852-54-8
Halobetasol Propionate( BMY-30056 | CGP-14458 | Ulobetasol propionate )
Catalog No. M18974 CAS No. 66852-54-8
Halobetasol Propionate is the propionate salt form of halobetasol, a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 33 | In Stock |
|
| 50MG | 41 | In Stock |
|
| 100MG | 65 | In Stock |
|
| 200MG | 91 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHalobetasol Propionate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHalobetasol Propionate is the propionate salt form of halobetasol, a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities.
-
DescriptionHalobetasol Propionate is the propionate salt form of halobetasol, a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities. Halobetasol, a topical steroid, diffuses across cell membranes to interact with cytoplasmic corticosteroid receptors located in both the dermal and intradermal cells, thereby activating gene expression of anti-inflammatory proteins mediated via corticosteroid receptor response element. Specifically, this agent induces phospholipase A2 inhibitory proteins, which inhibit the release of arachidonic acid, thereby inhibiting the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes. As a result, halobetasol reduces edema, erythema, and pruritus through its cutaneous effects on vascular dilation and permeability.
-
In Vitro——
-
In Vivo——
-
SynonymsBMY-30056 | CGP-14458 | Ulobetasol propionate
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorPLA2
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number66852-54-8
-
Formula Weight484.96
-
Molecular FormulaC25H31ClF2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 35 mg/mL; 72.17 mM
-
SMILESC(=O)(CC)O[C@@]1([C@H](C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@]12C)O)F)C)F)C)C(=O)CCl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
JNJ-5207852 dihydroc...
JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2?nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13?mg?kg?1, subcutaneously.
-
JNJ-18038683
JNJ-18038683 is a potent, selective 5-HT7 receptor antagonist with pKi of 8.19 and 8.20 for rat and human 5-HT7 in cell-based assays; decreases 5-HT (100 nM)-stimulated adenylyl cyclase in rat and human 5-HT7/HEK293 cells with pKb of 8.01 and 7.99, respectively.
-
Impromidine hydrochl...
Impromidine hydrochloride is a very potent and specific histamine H2 receptor agonist for conducting cardiovascular studies.
Cart
sales@molnova.com